[Cardiac resynchronization therapy in non-ischemic cardiomyopathy].
Cardiac resynchronization therapy is recommended in patients with advanced heart failure (usually NYHA class III or IV) despite optimal pharmacologic therapy, severe systolic dysfunction (eg, left ventricular ejection fraction < 35 percent) and intraventricular conduction delay or echocardiographic indices of dyssynchrony and wide QRS complex (eg, QRS > or = 120 ms). Viral infection is the most common cause of myocarditis and has been implicated in the development of non-ischemic cardiomyopathy. We report on a patient who developed progressive congestive heart failure caused by non-ischemic cardiomyopathy after liver transplantation and reactivation of the underlying hepatitis C. Due to an insufficient response to optimized pharmacological therapy, the patient was successfully treated using cardiac resynchronization therapy.
Weretka
S
S
Abteilung Innere Medizin III, Kardiologie, Medizinische Universitätsklinik Tübingen, Otfried-Mueller-Str. 10, 72076 Tübingen. slawomir.weretka@med.uni-tuebingen.de
Rüb
N
N
Weig
H J
HJ
Laszlo
R
R
Dörnberger
V
V
Gawaz
M
M
Schreieck
J
J
D006328:Cardiac Catheterization; D002311:Cardiomyopathy, Dilated / Q000150:complications / Q000209:etiology; D017023:Coronary Angiography; D004452:Echocardiography; D004554:Electric Countershock; D004562:Electrocardiography; D006333:Heart Failure / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000601:surgery; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged
Resynchronisationstherapie bei nicht-ischämischer Kardiomyopathie.